| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,755 |
3,319 |
$311K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,879 |
5,141 |
$304K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,703 |
1,491 |
$193K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,122 |
1,050 |
$115K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
951 |
907 |
$100K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,141 |
1,996 |
$95K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
857 |
754 |
$78K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
568 |
550 |
$67K |
| 99401 |
|
5,220 |
4,039 |
$65K |
| 90686 |
|
1,557 |
1,513 |
$35K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,590 |
2,402 |
$30K |
| 92551 |
|
2,993 |
2,866 |
$28K |
| 94760 |
|
10,277 |
8,877 |
$21K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
510 |
456 |
$17K |
| 99050 |
|
1,366 |
1,231 |
$14K |
| 90670 |
|
621 |
578 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
463 |
425 |
$11K |
| 99383 |
|
96 |
92 |
$11K |
| 99411 |
|
819 |
662 |
$9K |
| 90698 |
|
369 |
340 |
$8K |
| 99173 |
|
3,051 |
2,917 |
$8K |
| 69210 |
|
190 |
166 |
$7K |
| 96127 |
|
1,292 |
1,246 |
$7K |
| 96160 |
|
1,873 |
1,737 |
$6K |
| 90680 |
|
219 |
199 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
225 |
187 |
$4K |
| 90651 |
|
177 |
173 |
$4K |
| 90633 |
|
166 |
153 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
282 |
262 |
$3K |
| 99072 |
|
2,795 |
2,333 |
$3K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
446 |
430 |
$3K |
| 90744 |
|
118 |
103 |
$2K |
| 99382 |
|
20 |
20 |
$2K |
| 90656 |
|
113 |
110 |
$2K |
| 3008F |
|
2,119 |
1,998 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
16 |
$2K |
| 83655 |
|
157 |
141 |
$1K |
| 96161 |
|
620 |
541 |
$1K |
| 2015F |
|
127 |
115 |
$1K |
| 90661 |
|
46 |
43 |
$1K |
| 99381 |
|
16 |
12 |
$1K |
| 90734 |
|
50 |
50 |
$1K |
| A4208 |
Syringe with needle, sterile 3 cc, each |
3,078 |
2,893 |
$701.59 |
| 90710 |
|
25 |
25 |
$582.00 |
| 90620 |
|
14 |
14 |
$325.92 |
| 90696 |
|
13 |
13 |
$302.64 |
| 99000 |
|
1,222 |
1,066 |
$300.00 |
| 99051 |
|
40 |
38 |
$280.00 |
| 90715 |
|
12 |
12 |
$279.36 |
| 90677 |
|
12 |
12 |
$279.36 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$254.40 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
164 |
155 |
$75.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
18 |
16 |
$12.58 |
| 36416 |
|
417 |
297 |
$10.50 |